<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Leo P</submitter><funding>BLRD VA</funding><funding>NCATS NIH HHS</funding><funding>NIBIB NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>35</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8093226</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>Existing tools for post-radical prostatectomy (RP) prostate cancer biochemical recurrence (BCR) prognosis rely on human pathologist-derived parameters such as tumor grade, with the resulting inter-reviewer variability. Genomic companion diagnostic tests such as Decipher tend to be tissue destructive, expensive, and not routinely available in most centers. We present a tissue non-destructive method for automated BCR prognosis, termed "Histotyping", that employs computational image analysis of morphologic patterns of prostate tissue from a single, routinely acquired hematoxylin and eosin slide. Patients from two institutions (n = 214) were used to train Histotyping for identifying high-risk patients based on six features of glandular morphology extracted from RP specimens. Histotyping was va</pubmed_abstract><journal>NPJ precision oncology</journal><pubmed_title>Computer extracted gland features from H&amp;amp;E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.</pubmed_title><pmcid>PMC8093226</pmcid><funding_grant_id>I01 BX004121</funding_grant_id><funding_grant_id>U24 CA199374</funding_grant_id><funding_grant_id>UL1 TR002548</funding_grant_id><funding_grant_id>U54 CA254566</funding_grant_id><funding_grant_id>R43 EB028736</funding_grant_id><funding_grant_id>C06 RR012463</funding_grant_id><pubmed_authors>Janaki N</pubmed_authors><pubmed_authors>El-Fahmawi A</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Elliott R</pubmed_authors><pubmed_authors>Lee D</pubmed_authors><pubmed_authors>Khani F</pubmed_authors><pubmed_authors>Feldman M</pubmed_authors><pubmed_authors>Yamoah K</pubmed_authors><pubmed_authors>Farre X</pubmed_authors><pubmed_authors>Jambor I</pubmed_authors><pubmed_authors>Janowczyk A</pubmed_authors><pubmed_authors>Bera K</pubmed_authors><pubmed_authors>Aronen HJ</pubmed_authors><pubmed_authors>Magi-Galluzzi C</pubmed_authors><pubmed_authors>Rebbeck TR</pubmed_authors><pubmed_authors>Ettala O</pubmed_authors><pubmed_authors>Purysko A</pubmed_authors><pubmed_authors>Gupta S</pubmed_authors><pubmed_authors>Tewari A</pubmed_authors><pubmed_authors>Eklund L</pubmed_authors><pubmed_authors>Shiradkar R</pubmed_authors><pubmed_authors>Madabhushi A</pubmed_authors><pubmed_authors>Nc Shih N</pubmed_authors><pubmed_authors>Taimen P</pubmed_authors><pubmed_authors>Klein E</pubmed_authors><pubmed_authors>Merisaari H</pubmed_authors><pubmed_authors>Bostrom PJ</pubmed_authors><pubmed_authors>Leo P</pubmed_authors><pubmed_authors>Shahait M</pubmed_authors><pubmed_authors>Robinson BD</pubmed_authors><pubmed_authors>Lal P</pubmed_authors><pubmed_authors>Fu P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computer extracted gland features from H&amp;amp;E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.</name><description>Existing tools for post-radical prostatectomy (RP) prostate cancer biochemical recurrence (BCR) prognosis rely on human pathologist-derived parameters such as tumor grade, with the resulting inter-reviewer variability. Genomic companion diagnostic tests such as Decipher tend to be tissue destructive, expensive, and not routinely available in most centers. We present a tissue non-destructive method for automated BCR prognosis, termed "Histotyping", that employs computational image analysis of morphologic patterns of prostate tissue from a single, routinely acquired hematoxylin and eosin slide. Patients from two institutions (n = 214) were used to train Histotyping for identifying high-risk patients based on six features of glandular morphology extracted from RP specimens. Histotyping was va</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2026-06-02T18:34:22.08Z</modification><creation>2026-04-19T03:09:21.466Z</creation></dates><accession>S-EPMC8093226</accession><cross_references><pubmed>33941830</pubmed><doi>10.1038/s41698-021-00174-3</doi></cross_references></HashMap>